A. P. Moller Maersk A/S (DP4A)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 2,990.00 |
|---|---|
| 52-week range | 1,653.00 – 3,238.00 |
| Return, 1 month / 3 months | −0.1% / +34.0% |
| Return, 1 year / 3 years | +75.8% / +137.2% |
| Trend | Uptrend |
| RSI (14) | 43 |
| Volatility (1 year) | 35.1% |
| Worst drawdown (1 year) | -21.3% |
| Average daily value traded | 0.06M EUR |
| Dividend yield | 0.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
A. P. Moller Maersk is a Danish shipping and logistics group based in Copenhagen. Its main business is container shipping, moving goods for manufacturers, retailers and other customers across trade routes around the world. The company also operates port terminals and provides supply chain and logistics services, including freight forwarding and inland transport, that connect ocean carriage with land-based distribution for its customers.
On this site A. P. Moller Maersk A/S appears as a stock on the XETRA Stock Exchange (Germany), code DP4A, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
A. P. Moller Maersk A/S (DP4A) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 2,990.00 on 23 October 2026.
Its price-based Market X-Ray is 70 out of 100 (a strong price profile), ranking 101 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 75.8% and over the last three months it rose 34.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 90 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 29.4% | ||
| From 52-week high | -7.7% | ||
| Momentum | 95 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 34.0% | ||
| 6-month return | 52.0% | ||
| 12-month return, skipping the last month | 76.0% | ||
| Stability (higher is calmer) | 63 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 35.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.3% | ||
| Liquidity | 37 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.06M EUR | ||
| Zero-volume days | 1.7% | ||
| Income | 27 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.3% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −4.8% |
|---|---|
| 1 month | −0.1% |
| 3 months | +34.0% |
| 6 months | +52.0% |
| 1 year | +75.8% |
| 3 years | +137.2% |
| 5 years | – |
Signals
| 50-day / 200-day average | 2,974.12 / 2,311.36 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 76.97 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 26 Mar 2026 | DKK 64.1520 |
| 19 Mar 2025 | DKK 149.6880 |
| 15 Mar 2024 | DKK 68.8298 |
| 29 Mar 2023 | DKK 574.6950 |
| 16 Mar 2022 | DKK 334.1250 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.